Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features
Open Access
- 10 May 2018
- journal article
- research article
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 1-5
Abstract
Recent evidence suggests a role of androgen receptor expression as a prognostic and therapeutic biomarker in endometrial carcinoma, therefore in the present study we aimed to evaluate the frequency of androgen expression in different subtypes of endometrial carcinoma and its association with clinic-pathologic features. 18/89 (20.2%) cases of endometrial carcinoma showed positive androgen receptor expression. On the other hand, low, moderate and high androgen receptor expression was noted in 7/89 (7.9%), 10/89 (11.2%) and 1/89 (1.1%) cases respectively. 15/77 (19.48%) of endometrioid cancers and 3/7 (42.28%) cases of serous carcinoma showed androgen receptor expression; while none of the cases of clear cell or carcinosarcoma revealed androgen receptor expression. No significant association of androgen receptor expression with various clinicopathologic features of endometrial carcinoma was noted. We found that a significant subset of endometrial cancers express androgen receptor especially a serous cancers; therefore we suggest that androgen receptor expression testing should be done in endometrial carcinoma.Keywords
This publication has 15 references indexed in Scilit:
- Androgen Receptor Expression in Endometrial CarcinomaInternational Journal of Gynecological Pathology, 2018
- The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and SurvivalInternational Journal of Gynecological Pathology, 2017
- Bokhman Redux: Endometrial cancer “types” in the 21st centuryGynecologic Oncology, 2017
- Androgen receptor as potential therapeutic target in metastatic endometrial cancerOncotarget, 2016
- Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survivalBritish Journal of Cancer, 2016
- Hormonal therapy of endometrial cancerEuropean Journal of Cancer, 2005
- Expression of androgen receptor and 5α‐reductases in the human normal endometrium and its disordersInternational Journal of Cancer, 2002
- Epidemiology of endometrial cancerBest Practice & Research Clinical Obstetrics & Gynaecology, 2001
- Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancerMolecular Carcinogenesis, 2000
- CORRELATION OF ANDROGEN RECEPTORS WITH HISTOLOGICAL DIFFERENTIATION IN HUMAN ENDOMETRIAL CARCINOMASActa Obstetricia et Gynecologica Scandinavica, 1985